Author

Marion Strullu

InsermORCID 0000-0002-9229-0150Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Developmental Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

André BarucheliD· 1 shared Anne Quillet‐MaryiD· 1 shared Bastien GerbyiD· 1 shared Christine DidieriD· 1 shared Chuan YaniD· 1 shared Clémence RouzieriD· 1 shared Cyril BroccardoiD· 1 shared David M. LangenauiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

André BaruchelORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting glucocorticoid-induced CD20 activation in preclinical models of B-ALL

Jérémy Bigot, Mathieu Bouttier, Vincent Fregona, Clémence Rouzier, Manon Bayet, Sylvie Hébrard, Naïs Prade, Stéphanie Lagarde, Christine Didier, Laëtitia Largeaud, François Vergez, Anne Quillet‐Mary, Loïc Ysebaert, Cyril Broccardo, André Baruchel, , Bastien Gerby

This study identifies CD20 as an actionable target in B-ALL MRD using PDX models and single-cell RNA sequencing, showing anti-CD20 antibodies can eradicate drug-resistant cells.

bioRxiv · Dec 18, 2025 · PreprintCancer Biology

Inflammatory response in hematopoietic stem and progenitor cells triggered by activating SHP2 mutations evokes blood defects

Maja Šolman, Sasja Blokzijl-Franke, Florian Piques, Chuan Yan, Qiqi Yang, Marion Strullu, Sarah M. Kamel, Pakize Ak, Jeroen Bakkers, David M. Langenau, Hélène Cavé, Jeroen den Hertog

This study identifies an inflammatory response in HSPCs with SHP2 mutations that drives MPN and suggests anti-inflammatory agents as potential therapies for JMML.

eLife · Apr 20, 2022Peer-reviewedDevelopmental Biology